Literature DB >> 25431309

Hospitalisation costs for infant bronchiolitis are up to 20 times higher if intensive care is needed.

Paula Heikkilä1, Leena Forma, Matti Korppi.   

Abstract

AIM: Up to 3% of infants with bronchiolitis under 12 months of age are hospitalised, and up to 9% require intensive care. We evaluated the costs of bronchiolitis hospitalisation, with a special focus on whether infants needed intensive care.
METHODS: Baseline and cost data were retrospectively collected, using electronic hospital files, for 80 infants under 12 months old who were treated in the paediatric intensive care unit (PICU) for bronchiolitis during a 13-year period. We calculated the daily costs for patients admitted to the PICU and compared them with 104 admitted to inpatient wards and 56 outpatients treated in the emergency department.
RESULTS: The mean hospitalisation cost for PICU patients was €8061 (95% CI 6193-9929), compared to €1834 (1649-2020) for other inpatients and €359 (331-387) for the outpatients. The hospitalisation cost per patient was associated with length of hospital stay, but not gender, age on admission or gestational age. There was no constant increase or decrease in hospitalisation costs during the study period.
CONCLUSION: The hospitalisation costs of infants treated in the PICU for bronchiolitis at <12 months of age were approximately four times more than for other inpatients and over 20 times more than for outpatients. Strategies are needed to reduce the need for intensive care. ©2014 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Bronchiolitis; Healthcare provider; Hospitalisation costs; Length of hospitalisation; Paediatric intensive care

Mesh:

Year:  2015        PMID: 25431309     DOI: 10.1111/apa.12881

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  8 in total

1.  Changes in Bronchiolitis Incidence During the Last Two Decades in Tampere, Finland: A Retrospective Study.

Authors:  Tytti Vihikangas; Sauli Palmu; Anna-Maija Koivisto; Paula Heikkilä
Journal:  Pediatr Infect Dis J       Date:  2022-07-28       Impact factor: 3.806

2.  Families' costs form a considerable part of total costs in bronchiolitis care.

Authors:  Emilia Mäntynen; Sauli Palmu; Paula Heikkilä
Journal:  Health Sci Rep       Date:  2022-04-26

3.  The change in management of bronchiolitis in the intensive care unit between 2000 and 2015.

Authors:  Minna Mecklin; Paula Heikkilä; Matti Korppi
Journal:  Eur J Pediatr       Date:  2018-05-15       Impact factor: 3.183

Review 4.  The cost-effectiveness of hypertonic saline inhalations for infant bronchiolitis: a decision analysis.

Authors:  Paula Heikkilä; Minna Mecklin; Matti Korppi
Journal:  World J Pediatr       Date:  2018-02-23       Impact factor: 2.764

5.  Impact of hospitalizations for bronchiolitis in preterm infants on long-term health care costs in Italy: a retrospective case-control study.

Authors:  Daniela Paola Roggeri; Alessandro Roggeri; Elisa Rossi; Salvatore Cataudella; Nello Martini
Journal:  Clinicoecon Outcomes Res       Date:  2016-08-04

6.  Marked variability observed in inpatient management of bronchiolitis in three Finnish hospitals.

Authors:  Varpu Elenius; Eija Bergroth; Petri Koponen; Sami Remes; Pedro A Piedra; Janice A Espinola; Matti Korppi; Carlos A Camargo; Tuomas Jartti
Journal:  Acta Paediatr       Date:  2017-06-16       Impact factor: 2.299

7.  Prenatal Versus Postnatal Tobacco Smoke Exposure and Intensive Care Use in Children Hospitalized With Bronchiolitis.

Authors:  Michelle D Stevenson; Jonathan M Mansbach; Eugene Mowad; Michelle Dunn; Sunday Clark; Pedro A Piedra; Ashley F Sullivan; Carlos A Camargo
Journal:  Acad Pediatr       Date:  2015-11-06       Impact factor: 3.107

8.  Cost-effectiveness study of early versus late parenteral nutrition in critically ill children (PEPaNIC): preplanned secondary analysis of a multicentre randomised controlled trial.

Authors:  Esther van Puffelen; Suzanne Polinder; Ilse Vanhorebeek; Pieter Jozef Wouters; Niek Bossche; Guido Peers; Sören Verstraete; Koen Felix Maria Joosten; Greet Van den Berghe; Sascha Cornelis Antonius Theodorus Verbruggen; Dieter Mesotten
Journal:  Crit Care       Date:  2018-01-15       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.